Renaissance Pharma
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.renaissancepharma.co.ukRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Renaissance Pharma
Renaissance Pharma Ltd is a clinical stage biopharmaceutical company dedicated to enhancing treatment options for rare paediatric diseases, particularly focusing on high-risk neuroblastoma. Their lead project aims to develop new antibody-based therapeutics to improve outcomes for affected children. The company is committed to advancing life-changing therapies in the field of paediatric medicine. Recently, they have entered into a licensing agreement for a promising treatment from St. Jude Children's Hospital.Explore more
Popular SearchesRenaissance PharmaSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Renaissance Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Renaissance Pharma recently announced quarterly report
Renaissance Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Renaissance Pharma had a recent Job posting/layoffs
Check out if Renaissance Pharma is spiking on competitors!
Check if Renaissance Pharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Renaissance Pharma
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Renaissance Pharma launches new products
Funding: Get notified immidiatlly once Renaissance Pharma has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Renaissance Pharma Tech Stack
A closer look at the technologies used by Renaissance Pharma
Renaissance Pharma News & Media
Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma
UK – 14 April 2026 – Renaissance Pharma Limited, an Essential Pharma company focused on development stage assets, today announces that the US Food and Drug Administration (FDA) has granted Fast Track Designation for Daretabart (hu1418K322A), a novel anti-GD2 monoclonal antibody in development for the treatment of high-risk neuroblastoma (HRNB), a rare paediatric cancer. The designation recognises the significant unmet medical need in HRNB and will support more frequent interactions with the FDA
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Renaissance Pharma
Sign Up For FreeTo access detailed company insights
Renaissance Pharma Ltd is a clinical stage biopharmaceutical company dedicated to enhancing treatment options for rare paediatric diseases, particularly focusing on high-risk neuroblastoma. Their lead project aims to develop new antibody-based therapeutics to improve outcomes for affected children. The company is committed to advancing life-changin... Read More
